Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

This policy (A58729) is a response-to-comments document for MolDX LCD L38576 concerning prognostic and predictive molecular classifiers for bladder cancer. It does not establish coverage criteria; consult LCD L38576 (notice 06/03/2021, effective 07/18/2021) for indications, limitations, documentation requirements, and frequency limits.

"This document is a response to public comments on MolDX Local Coverage Determination L38576 for prognostic and predictive molecular classifiers for bladder cancer and does not itself define coverag..."

Sign up to see full coverage criteria, indications, and limitations.